Full Text View
Tabular View
No Study Results Posted
Related Studies
Efficacy and Safety of Prandial Inhalation of Technosphere/Insulin in Combination With Metformin or Technosphere/Insulin Alone Versus 2 Oral Anti-Diabetic Agents in Subjects With Type 2 Diabetes
This study has been completed.
First Received: May 31, 2006   Last Updated: October 1, 2009   History of Changes
Sponsor: Mannkind Corporation
Information provided by: Mannkind Corporation
ClinicalTrials.gov Identifier: NCT00332488
  Purpose

to demonstrate the efficacy of inhaled Technosphere/Insulin in combination with metformin versus combination metformin and a secretagogue


Condition Intervention Phase
Diabetes Mellitus, Type 2
Drug: Technosphere Insulin
Drug: Metformin & Secretagogues
Drug: Technosphere Insulin & Metformin
Phase III

Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Active Control, Crossover Assignment, Safety/Efficacy Study
Official Title: A Phase 3, 24-Week, Multi-Center, Open-Label, Randomized, Controlled Trial Comparing the Efficacy and Safety of Prandial Inhalation of Technosphere/Insulin in Combination With Metformin or Technosphere/Insulin Alone Versus 2 Oral Anti-Diabetic Agents (Metformin and a Secretagogue) in Subjects With Type 2 Diabetes Mellitus Sub-optimally Controlled on Combination Metformin and a Secretagogue.

Resource links provided by NLM:


Further study details as provided by Mannkind Corporation:

Primary Outcome Measures:
  • Change from baseline to Week 12 in glycated hemoglobin [ Time Frame: 12 weeks ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Change in HbA1c from baseline [ Time Frame: 24 weeks ] [ Designated as safety issue: No ]

Enrollment: 547
Study Start Date: December 2004
Estimated Study Completion Date: October 2008
Primary Completion Date: March 2008 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
1: Experimental
Technosphere Insulin
Drug: Technosphere Insulin
Inhalation, 15U/30U, prandial
2: Active Comparator
Metformin & Secretagogues
Drug: Metformin & Secretagogues
Metformin tablets,Secretagogues supplied as any of the currently marketed brands and formulations.
3: Experimental
Technosphere & Metformin
Drug: Technosphere Insulin & Metformin
Technosphere Insulin Inhalation Powder 15U/30U, Metformin tablets

  Eligibility

Ages Eligible for Study:   18 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Non-smokers with clinical diagnosis of Type 2 diabetes mellitus for >or= to 6 months
  • Stable regimen of metformin for > or = to 1000mg/day 9or maximum tolerated dose) and a secretagogue < or = 1/2 the maximum manufacturer-recommended daily dose without any dose adjustments within the preceding 6 wks.
  • Fixed dose combination products of metformin and sulfonylurea are acceptable as long as each individual dose meets inclusion criteria
  • HbA1c >or= to 7.5% and < or= to 11.0%
  • BMI < or = to 40kg/m2.
  • FEV1> or = to 70%, Total Lung capacity and > or =80% DLco > or= to 70%

Exclusion Criteria:

  • Treatment with any type of anti-diabetic therapy, other than metformin & secretagogues within the preceding 12 weeks
  • Serum creatinine > 1.4mg/dL in female subjects and >1.5mg/dL in male subjects
  • History of chronic obstructive pulmonary disease, clinically proven asthma and/or any other clinically important pulmonary function testing and/or radiologic findings
  • Evidence of serious complications of diabetes (e.g. autonomic neuropathy)
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00332488

  Hide Study Locations
Locations
United States, Alabama
Radiant Research-Birmingham
Birmingham, Alabama, United States, 35209
Parkway Medical Center
Birmingham, Alabama, United States, 35215
United States, Arizona
Redpoint Research
Phoenix, Arizona, United States, 85029
Arizona Center for Clinical Research
Phoenix, Arizona, United States, 85032
United States, California
International Clinical Research Network
Chula Vista, California, United States, 91911
United States, Colorado
Jennifer Hone MD
Denver, Colorado, United States, 80220
Creekside Endocrine Associates
Denver, Colorado, United States, 80209
National Jewish Medical & Research Center
Denver, Colorado, United States, 80206
United States, Connecticut
Chase Medical Research, LLC
Waterbury, Connecticut, United States, 06708
United States, Florida
Center for Diabetes & Endocrine Care
Hollywood, Florida, United States, 33021
International Research Associates LLC
Miami, Florida, United States, 33156
United States, Illinois
John H Stoger Jr Hospital of Cook County
Chicago, Illinois, United States, 60612
Cedar-Crosse Research Center
Chicago, Illinois, United States, 60607
Clintell Inc
Skokie, Illinois, United States, 60076
United States, Maryland
James A Dicke MDPA
Towson, Maryland, United States, 21204
United States, Massachusetts
East Coast Clinical Research Inc
Haverhill, Massachusetts, United States, 01830
United States, Michigan
Wayne State University
Detroit, Michigan, United States, 48201
Michigan Institute of Medicine
Livonia, Michigan, United States, 48152
United States, Missouri
Raidant Research-St Louis
St Louis, Missouri, United States, 63141
Clayton Medical Research
St Louis, Missouri, United States, 63117
Washington University School of Medicine
St. Louis, Missouri, United States, 63110
United States, Nebraska
Creighton Diabetes Center
Omaha, Nebraska, United States, 68131
United States, New Mexico
Lovelace Scientific Resources (Albuquerque)
Albuquerque, New Mexico, United States, 87108
United States, New York
North Shore Diabetes and Endocrine Associates
New Hyde Park, New York, United States, 11042
Winthrop University Hospital
Mineola, New York, United States, 11501
United States, North Carolina
Charlotte Clinical Research Inc
Charlotte, North Carolina, United States, 28211
Sensenbrenner Primary Care
Charlotte, North Carolina, United States, 28277
Metrolina Internal Medicine
Charlotte, North Carolina, United States, 28204
Duke Medical Center
Durham, North Carolina, United States, 27710
United States, Ohio
Providence Health Partners - Center of Clinical Research
Dayton, Ohio, United States, 45439
Dayton Clinical Research
Dayton, Ohio, United States, 45406
United States, Oregon
Radiant Research
Portland, Oregon, United States, 97239
United States, South Carolina
Upstate Pharmaceutical Research
Greenville, South Carolina, United States, 29615
United States, Tennessee
GoodLife Medical Center PLLC
Memphis, Tennessee, United States, 38120
Memphis Internal Medicine (Kathawala)
Memphis, Tennessee, United States, 38119
Collierville Medical Specialists
Collierville, Tennessee, United States, 38017
United States, Texas
Clinical Trials of Texas Inc
San Antonio, Texas, United States, 78229
Covenant Clinic Research
San Antonio, Texas, United States, 78229
Diabetes & Glandular Disease Research Assoc PA
San Antonio, Texas, United States, 78229
Quality Assurance Research Center Inc
San Antonio, Texas, United States, 78205
Baylor Endocrine Center
Dallas, Texas, United States, 75246
SAM Clinical Research Center
San Antonio, Texas, United States, 78229
United States, Washington
Cedar Research
Tacoma, Washington, United States, 98405
Argentina
Centro Endocrinologic Tiempo
Buenos Aires, Argentina, C1117ABH
CIMeL
Buenos Aires, Argentina
Hospital Italiano de Buenos Aires
Buenos Aires, Argentina, C1181ACH
Cons Asoc de Endocrinologia
Buenos Aires, Argentina, C1425AGC
Argentina, Buenos Aires
Hospital Interzonal de Agudos Pedro Fiorito
Avellaneda, Buenos Aires, Argentina, B1870ARG
Brazil
Ccbr Brasil Centro de Analises e Pesquisas Clinicas Ltda
Rio de Janeiro, Brazil, 22271-100
Hospital Guilherme Alvaro
Santos, Brazil, 11045-904
Instituto de Pesquisa Clinica e Medicina Avancada
Sao Paulo, Brazil, 05437-010
CPClin-Centro de Pesquisas Clinicas
Sao Paulo, Brazil, 01244-030
UNIFRSP
Sao Paulo, Brazil, 04020-050
Hospital do Rim e Hipertensao
Sao Paulo, Brazil, 04025-011
Brazil, Rio Grande do Sul
Hospital Sao Lucas da PUCRS
Porto Alegre, Rio Grande do Sul, Brazil, 90610-000
Hospital de Clinicas de Porto Alegre
Porto Alegre, Rio Grande do Sul, Brazil, 90035-903
Canada
Unimedico Management
Richmond Hill, Canada, L4C 9M7
Canada, Ontario
Lifestyle Metabolism Center
Oakville, Ontario, Canada, L6H 3P1
Lifestyle Metabolism Center
Thornhill, Ontario, Canada, L4J 8L7
Lifestyle Metabolism Center
Toronto, Ontario, Canada, M4R 2G4
Quest Clinical Trials
Markham, Ontario, Canada, L6B 1A1
Trial Management Group Inc (Henein
Toronto, Ontario, Canada, M4T 1N5
Chile
Hospital Clinico Pontificia Universidad Catolica de Chile
Santiago, Chile
Hospital del Salvador
Santiago, Chile
Instituto de Informacion de Tramiento y Educacion en Salud
Santiago, Chile
Chile, Region Metropolitana
Hospital Padre Alberto Hurtado
Santiago, Region Metropolitana, Chile
Czech Republic
Diabetologicka ambulance (Chmura)
Ostrava, Czech Republic, 70200
Endokrinologicky ustav
Praha 1, Czech Republic, 11694
3rd Medical Department General Faculty Hospital
Praha 2, Czech Republic, 12801
II interni klinika FN Kralovske Vinohrady
Praha 10, Czech Republic, 10034
Interní a diabetologická Outpatient
Ostrava, Czech Republic, 70900
Czech Republic, CZE
Institute for Clinical and Exp Medicine
Prague 4, CZE, Czech Republic, 140 21
University Hospital Na Bulovce
Prague 8, CZE, Czech Republic, 180 81
Diabetologicka a interni ambulance
707 02 Ostrava-Kuncice, CZE, Czech Republic, 70702
Mexico
Hospital General de Mexico Servicio EndocrinologiaJefe Del Servicio
Mexico City, Mexico, 06726
Centro de Estudios en Diabetes
Mexico City, Mexico, 01120
OCA-MIRC
Monterrey, Mexico, 64020
Hospital Santa Engracia-CIMA
Garza Garcia, Mexico, 66260
Mexico, Durango
Instituto Mexicano de Investigacion
Mexico City, Durango, Mexico, 06700
Mexico, Nuevo Leon
Hospital Universitario Dr Jose E Gonzalez
Monterrey, Nuevo Leon, Mexico, 64460
Poland
Oddzial Kliniczny Diabetologii (009) Kliniczny nr 1 im Norberta Barlickiego Uniwersytety Meycznego
Lodz, Poland, 90-153
Niepubliczny Zaklad Opieki Zdrowotnej VIVAMED
Warsaw, Poland, 03 580
Centrum Leczenia Chorob cywilizacyjnych
Warszawa, Poland, 02 777
Poland, POL
NZOZ Specjalistyczny Osrodek Internistyczno - Diabetologiczny
Bialystok, POL, Poland, 15-435
Instytut Centrum Zdrowia (009) Matki Polki
Lodz, POL, Poland, 93-338
Katedra I Klinika Chorob Metabolicznych Collegium Medicum Uniwersytety Jagiellonskiego
Krakow, POL, Poland, 31 501
Spzital Kolejowy imm Wlodzimierza Roeflera
Pruszkow, POL, Poland, 05-800
Klinika Endocrinologii Diabetologii I
Bialystock, POL, Poland, 15-276
Russian Federation
NI Central Clinical Hospital of RAS
Moscow, Russian Federation, 117 593
Russian Federation, RUS
NHI Kemerovo Regional Clinical Hospital
Kemerovo, RUS, Russian Federation, 650061
NI Moscow Regional Scientific Research Clinical Institute na MF Vladimirsky
Moscow, RUS, Russian Federation, 129110
Central Medical Sanitary Unit #122
St Petersburg, RUS, Russian Federation, 194291
NI Principal Military Clinical Hospital n a academician N.N. Burdenko of the Ministry of Defense
Moscow, RUS, Russian Federation, 105229
MHI Clinical Hospital for Emergency Care na NV Soloviev
Yaroslavl, RUS, Russian Federation, 150003
St Petersburg NHI Municipal Multi-Speciality Hospital # 2
St. Petersburg, RUS, Russian Federation, 194354
NEI HPE Moscow State University of Medicine and Dentistry of FAHSD City Clinical Hospital #70
Moscow, RUS, Russian Federation, 111399
TUV Medico-Military Academy
St Petersburg, RUS, Russian Federation, 198013
St Petersburg NHI City Polytclinic #77 City Diabetological Center #4
St Petersburg, RUS, Russian Federation, 193012
NHI Yaroslavl Regional Clinical Hospital
Yaroslavl, RUS, Russian Federation, 150062
NI Endrocrinological Research Centre of RAMS In patient replacing technologies department
Moscow, RUS, Russian Federation, 115478
NEI HPE Smolensk State Medical Academy of FAHSD RNHI Smolensk Regional Clinical Hospital
Smolensk, RUS, Russian Federation, 214018
Spain
Hospital Ramon y Cajal
Madrid, Spain, 28034
Hospital Clinic I Provincial
Barcelona, Spain, 08036
Corporacion Sanitaria Parc Tauli Unidad de Endocrinologia
Sabadell, Spain, 08208
Hospital Universitario de la Princessa
Madrid, Spain, 28006
Spain, Andalucia
Complejo Hospitalario Nuestra Senora de Valme
Sevilla, Andalucia, Spain, 41014
Ukraine
Public Institution City Policlinic #20 Odessa
Odessa, Ukraine, 65114
Outpatient Clinic of Family Physician "Rusanovka"
Kiev, Ukraine, 02147
Ukraine, UKR
Railway Clinical Hospital on Donetsk Station
Donetsk, UKR, Ukraine, 83114
Ukr Scientifically Practical Centre of Endocrine Surgery
Kiev, UKR, Ukraine, 2175
Donetsk State Medical University
Donetsk, UKR, Ukraine, 83003
Institute of Endocrinology and Metabolism
Kiev, UKR, Ukraine, 04114
Odessa Reg. Clinical Hosp Outpatient Department
Odessa, UKR, Ukraine, 65025
Odessa State Medical University Dept of Gen Practice and Med Rehab
Odessa, UKR, Ukraine, 65009
Donetsk State Medical University (Chair of Immun Allergogoly & Endocrin)
Donetsk, UKR, Ukraine, 83099
Bukovinian State Medical University Dept of Clinical Immun
Chernivtsy, UKR, Ukraine, 58022
Dniepropetrovsh State Medical Academy
Dniepropetrovsk, UKR, Ukraine, 49023
Vinnitsa State Medical University
Vinnitsa, UKR, Ukraine, 21010
Chair Family Med of National Med University
Kiev, UKR, Ukraine, 04050
Odessa State Med Dept of Family Med and Gen Practice
Odessa, UKR, Ukraine, 65039
Sponsors and Collaborators
Mannkind Corporation
Investigators
Study Director: Anders Boss Mannkind Corporation
  More Information

No publications provided

Responsible Party: MannKind Corporation ( Anders Boss, MD, MFPM, Chief Medical Officer )
Study ID Numbers: MKC-TI-103
Study First Received: May 31, 2006
Last Updated: October 1, 2009
ClinicalTrials.gov Identifier: NCT00332488     History of Changes
Health Authority: United States: Food and Drug Administration

Additional relevant MeSH terms:
Hypoglycemic Agents
Metabolic Diseases
Physiological Effects of Drugs
Metformin
Diabetes Mellitus, Type 2
Diabetes Mellitus
Endocrine System Diseases
Glucose Metabolism Disorders
Pharmacologic Actions
Insulin

ClinicalTrials.gov processed this record on November 27, 2009